Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Biologic Trials

California

Colorectal cancer biologic therapy trials in California

19 colorectal cancer biologic therapy studies are recruiting participants at sites in 32 cities across California as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 413-6546
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse California by city

Cities with the most studies recruiting right now.

Every California city with a recruiting study

Los Angeles (13), Duarte (6), Santa Monica (5), Los Alamitos (3), Sacramento (3), San Francisco (3), Santa Rosa (3), Bakersfield (2), Glendale (2), Irvine (2), Newport Beach (2), Torrance (2), Berkeley (1), Corona (1), Costa Mesa (1), Encinitas (1), Fountain Valley (1), Fremont (1), Fullerton (1), Huntington Beach (1), La Jolla (1), Long Beach (1), Orange (1), Palo Alto (1), Roseville (1), San Diego (1), San Mateo (1), South Pasadena (1), Sunnyvale (1), Upland (1), Vista (1), Whittier (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in California

Basic details from each study's public record (the 12 most recently updated of 19). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Fountain Valley · Los Angeles · Sacramento · and 1 more U.S. location
    Registry record
    NCT06997497 · updated
  2. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Costa Mesa · Irvine · Los Angeles · and 1 more U.S. location
    Registry record
    NCT06102902 · updated
  3. A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Los Angeles
    Registry record
    NCT05379595 · updated
  4. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Bakersfield · Glendale · Los Alamitos · and 4 more U.S. locations
    Registry record
    NCT06662786 · updated
  5. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Bakersfield · Glendale · Los Alamitos · and 4 more U.S. locations
    Registry record
    NCT06750094 · updated
  6. A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Los Angeles
    Registry record
    NCT06428409 · updated
  7. A Study of MGC026 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Recruiting in
    Los Angeles
    Registry record
    NCT06242470 · updated
  8. A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GlaxoSmithKline
    Recruiting in
    Los Alamitos · Los Angeles · Santa Monica · and 1 more U.S. location
    Registry record
    NCT06885034 · updated
  9. Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Recruiting in
    Corona · Duarte · Huntington Beach · and 4 more U.S. locations
    Registry record
    NCT07595874 · updated
  10. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Berkeley · Encinitas · Fremont · and 10 more U.S. locations
    Registry record
    NCT07222800 · updated
  11. A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Dispatch Biotherapeutics
    Recruiting in
    Duarte · Newport Beach
    Registry record
    NCT07544589 · updated
  12. A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Duarte · Los Angeles · Newport Beach · and 1 more U.S. location
    Registry record
    NCT05877599 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in California on ClinicalTrials.gov.

Ask about studies in California

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.

Colorectal Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 413-6546

or send a short form

How should we reach you?

Call